Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Celgene Corp Sees FY 2012 Revenue Guidance At Low End Of Prior Range; Issues FY 2015 Guidance In Line With Analysts' Estimates-Conference Call


Wednesday, 14 Nov 2012 05:30pm EST 

Celgene Corp announced that for fiscal 2012, it expects revenue of about $5.5 billion. The Company also expects revenue to be in the range of $8 billion to $9 billion and EPS to be in the range of $8 to $9 in fiscal 2015. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $5.5 billion for fiscal 2012; revenue of $8 billion and EPS of $8.26 for fiscal 2015. 

Company Quote

93.43
-1.35 -1.42%
1 Oct 2014